Showing results (21-30 of 42) with videos related to
Sort By:
Pageof 5
SLAS Discovery : Advancing Life Sciences R & D|December 14, 2018
Positioning High-Throughput CETSA in Early Drug Discovery through Screening against B-Raf and PARP1Joseph Shaw, Ian Dale, Paul Hemsley, et al.Cancer Prevention Research (Philadelphia, Pa.)|October 1, 2020
PROgesterone Therapy for Endometrial Cancer Prevention in Obese Women (PROTEC) Trial: A Feasibility StudyAbigail E Derbyshire, Jennifer L Allen, Matthew Gittins, et al.Molecular Biology of the Cell|February 21, 2014
Kdm3a lysine demethylase is an Hsp90 client required for cytoskeletal rearrangements during spermatogenesisIoannis Kasioulis, Heather M Syred, Peri Tate, et al.Cancers|January 11, 2024
Real-World Concordance between Germline and Tumour <i>BRCA1/2</i> Status in Epithelial Ovarian CancerRobert D Morgan, George J Burghel, Helene Schlecht, et al.Journal of Thrombosis and Haemostasis : JTH|October 23, 2024
Impact of limited language proficiency on participation in venous thromboembolism research: a retrospective analysisDesmond Anuku, Marc Carrier, Grégoire Le Gal, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2018
PRE-surgical Metformin In Uterine Malignancy (PREMIUM): a Multi-Center, Randomized Double-Blind, Placebo-Controlled Phase III TrialSarah J Kitson, Zoe Maskell, Vanitha N Sivalingam, et al.ACS Medicinal Chemistry Letters|September 19, 2019
Structural and Molecular Insight into Resistance Mechanisms of First Generation cMET InhibitorsGavin W Collie, Cheryl M Koh, Daniel J O'Neill, et al.Journal of Medicinal Chemistry|July 11, 2024
Discovery of a Series of Orally Bioavailable Androgen Receptor Degraders for the Treatment of Prostate CancerSharan K Bagal, Peter C Astles, Coura Diène, et al.Journal of Clinical Pathology|June 23, 2022
Predicting the likelihood of a <i>BRCA1/2</i> pathogenic variant being somatic by testing only tumour DNA in non-mucinous high-grade epithelial ovarian cancerRobert D Morgan, George J Burghel, Nicola Flaum, et al.British Journal of Cancer|November 16, 2024
Germline BRCA1/2 status and chemotherapy response score in high-grade serous ovarian cancerRobert D Morgan, Xin Wang, Bethany M Barnes, et al.Pageof 5